Table 2.
Demographics and Scan Characteristics of External Clinical Cohorts
| AdipoRedOx Cohort (n = 253) | SCOT-HEART Cohort (n = 1,558) | |
|---|---|---|
| Age, y | 67 (59-74) | 58 (47-69) |
| Male | 220 (87.0) | 887 (56.9) |
| BMI, kg/m2 | 27.9 (25.0-31.1) | 28.7 (25.1-33.2) |
| Active smoking | 127 (50.2) | 298 (19.1) |
| Hypertension | 186 (73.5) | 541 (34.7) |
| Hypercholesterolemia | 227 (89.7) | 810 (52.0) |
| Diabetes mellitus | 55 (21.7) | 173 (11.1) |
| Valve disease | 48 (19.0) | 144 (9.2) |
| Known CAD | 253 (100) | 158 (10.1) |
| Atrial fibrillation | 18 (7.1) | 32 (2.1) |
| Previous heart surgery | 253 (100) | 33 (2.1) |
| Scans | ||
| Site | Oxford GE Revolution GSI GE Lightspeed VCT Canon Aquilion One |
Scotland Philips Brilliance 64 Siemens Biograph mCT Canon Aquilion One |
| Scanner make and model | ||
| Tube voltage, kVp | ||
| 120 | 253 (100) | 846 (54.3) |
| 100 | 0 (0) | 712 (45.7) |
| 80 | 0 (0) | 0 (0) |
| EAT volume, cm3 | 162.9 (103.3-223.3) | 130.1 (94.2-171.6) |
Values are n (%) or median (IQR).
AdipoRedOx = Adipose tissue and cardiovascular RedOx regulation; SCOT-HEART = Scottish Computed Tomography of the Heart; other abbreviations as in Table 1.